Ankrd42: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Target Name: ANKRD42

NCBI ID: G338699

ANKRD42

Ankrd42: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

ANKRD42 (ANR42-HUMAN), a protein that belongs to the ANKRD4 family, is a potential drug target and biomarker associated with various diseases, including neurodegenerative disorders, pain, and inflammation.

The ANKRD4 family is a family of proteins that contain a unique domain called the N-terminal alpha-helical region (N-alpha), which is known for its ability to form helices and to have a flexible structure. This domain is also involved in the interaction with other proteins and in the regulation of various cellular processes, including cell growth, differentiation, and inflammation.

One of the ANKRD4 proteins that has received particular attention is ANKRD42 (ANR42-HUMAN). This protein was first identified as a potential drug target and biomarker in the brain due to its expression in the brain and its ability to interact with other proteins involved in neurodegenerative disorders.

The ANKRD42 protein is involved in various cellular processes that are relevant to neurodegenerative disorders, including the regulation of neurotransmitter release, synaptic plasticity, and neuroprotection. It has been shown to interact with proteins involved in the production and degradation of neurotransmitters, such as dopamine and serotonin, and to play a role in the regulation of synaptic plasticity and neuroprotection.

In addition to its involvement in neurodegenerative disorders, ANKRD42 has also been shown to be involved in the regulation of pain and inflammation. It has been shown to interact with proteins involved in the production and processing of pain signals, including nociceptants and opioids, and to play a role in the regulation of inflammation.

The potential drug target and biomarker properties of ANKRD42 make it an attractive target for research into the treatment of various neurological and psychiatric disorders, including neurodegenerative disorders, pain, and inflammation. Further studies are needed to fully understand the role of ANKRD42 in these processes and to develop effective treatments based on this protein.

Protein Name: Ankyrin Repeat Domain 42

The "ANKRD42 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD42 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets